Polymer Factory Receives Approx. SEK 2.05 Million Through 100% Exercise of Warrants of Series TO1
- PolymerFactory
- 2 days ago
- 2 min read
Polymer Factory Sweden AB (“Polymer Factory” or the “Company”) today announces that all 2,737,772 outstanding warrants of series TO1 have been exercised by investors. Through the exercise, the Company will receive approximately SEK 2,053,329 before deduction of transaction costs.
“It is encouraging and demonstrates strength that 100 percent of all warrants have been exercised,” says Mats Wallnér, CEO of Polymer Factory. “This shows continued strong confidence from our investors and provides us with increased resources to execute on our growth plans.”
The subscription period for the TO1 warrants ended on 12 of september 2025. Each warrant entitled the holder to subscribe for one (1) new share in the Company. As a result, the number of shares in Polymer Factory will increase by 2,737,772, thereby strengthening the Company’s capital base for future initiatives.
This disclosure contains information that Polymer Factory is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, on 17-09-2025 08:00 CET.
For more information, please contact:
Mats Wallnér, acting CEO
Phone: +46 (0) 70 951 95 06
E-mail: mats.wallner@polymerfactory.com
About Polymer Factory
Polymer Factory was founded in 2006 at KTH Royal Institute of Technology and its Board of Directors have been essential in driving dendritic nanotechnology research to commercialization for almost 15 years – expertise that has been transferred to the Company’s products. Emerging from many years of cutting-edge research within the field, Polymer Factory today has, in the Company’s assessment, the world’s largest product portfolio of dendritic materials with customers ranging from Big Pharma, MedTech and BioTech companies, to research-intensive institutes and academic research groups. Polymer Factory has also used the Company’s vast knowledge and expertise to develop a patented calibration technology, named SpheriCal®, designed for Mass Spectrometry instruments.